I’m pleased to report that we have already amassed health and genomic data on 265 children and young adults with A-T through our on-line Global A-T Family Data Platform. Contributing families span 25 countries, facilitated by the portal’s functionality in 10 languages.

Now, research scientists have begun plunging into these de-identified data sets, seeking discoveries both to improve the management of disease symptoms and to develop new therapies for A-T, all the while increasing our understanding of A-T. And, overseen by A-T parents from around the world, a team of distinguished scientists and clinicians on our Data Access Committee have begun selectively granting access to researchers who are planning unique data analysis projects.

This progress is only the beginning, and we know already that this data platform will have a tremendous impact. But, the more data sets we have, the better and faster will be the discoveries that emerge. We are therefore eager to continue finding and encouraging A-T families around the world to join the platform.

If you’d like to participate as either a family member or a researcher, please visit atfamilies.orgtoday. Thank you.

Brad Margus
Volunteer Chairman and Founder

Contact Us

Related News

Jul 22 @ 9:50 am

Gene Therapy for A-T Conference Announced For This Fall

The A-TCP is hosting an international Gene Therapy for A-T conference in November.

more
Jul 22 @ 9:50 am

Art of Nursing Award

A-T Clinic Nurse, Jenny Wright, RN is the recipient of the 2024 Art of Nursing award!

more
Jul 22 @ 9:50 am

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

more
Jul 22 @ 9:50 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

more